Please note, this webinar was originally scheduled to take place on June 25, 2026.
Overview
Join representatives from SCAI, the Society of Interventional Radiology (SIR), the Society of Vascular and Interventional Neurology (SVIN), and the Society for Vascular Surgery (SVS) to discuss the CREST-2 Study, which compares three different stroke prevention methods for patients with asymptomatic carotid stenosis: medical management alone, medical management plus carotid stenting, and medical management plus carotid endarterectomy.
This multidisciplinary panel of experts will discuss how the study's results will impact clinical practice.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Summarize CREST 2 findings as they relate to carotid stenting and carotid endarterectomy
- Apply CREST-2 findings to appropriately selected patients
- Summarize the components of best medical therapy
Agenda
- Moderators: Drs. Kenmuir and Metzger
- Updates in Carotid Endarterectomy, Dr. AbuRahma
- Carotid Revascularization Trial Review, Dr. Aronow
- TCAR: What Do We Know — and What Don't We Know? Dr. Goodney
- Insights in Tranfermoral Carotid Stenting, Dr. Heran
- CREST-2 Trial: Rationale, Design, and Key Findings, Dr. Jovin
- Best Medical Therapy: Implications for Practice, Dr. Chebl
Herbert D. Aronow, MD, MPH, MSCAI
Registration
Cost: Free
Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from Terumo.
Accredited Continuing Education Information
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
SCAI designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.25 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful Completion
Participate in the live activity and complete the evaluation to obtain credit.
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
Planning Process
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.
All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.
Faculty will not actively promote or sell products or services that serve their personal professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.
Events Schedule
Learning opportunities from SCAI for the interventional cardiology team.